-
Something wrong with this record ?
Transient hyperphosphatasemia in pediatric renal transplant patients--is there a need for concern and when?
S. Kutílek, S. Skálová, J. Vethamuthu, P. Geier, J. Feber,
Language English Country Denmark
Document type Case Reports, Journal Article
NLK
Medline Complete (EBSCOhost)
from 1999-01-01 to 1 year ago
Wiley Online Library (archiv)
from 1999-01-01 to 2012-12-31
- MeSH
- Alkaline Phosphatase blood MeSH
- Biopsy MeSH
- Child MeSH
- Hyperphosphatemia etiology therapy MeSH
- Bone and Bones pathology MeSH
- Humans MeSH
- Nephrotic Syndrome therapy MeSH
- Child, Preschool MeSH
- Protein Isoforms MeSH
- Renal Insufficiency therapy MeSH
- Kidney Transplantation methods MeSH
- Treatment Outcome MeSH
- Wrist radiography MeSH
- Check Tag
- Child MeSH
- Humans MeSH
- Male MeSH
- Child, Preschool MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Case Reports MeSH
TH of infancy and early childhood is characterized by transiently increased S-ALP, predominantly its bone or liver isoforms. There are neither signs of metabolic bone disease or hepatopathy corresponding to the increased S-ALP, nor a common underlying/triggering disease. TH may also occur in children post-renal Tx, which may raise significant concerns and anxiety. We describe four patients aged 2.8-7 yr in whom the TH occurred at 11-34 (median = 28) months after Tx and lasted from 40 to 105 (median = 63) days. No obvious cause/trigger of TH could be found; the clinical status and bone turnover were not altered. In cases of TH post-Tx, we recommend the evaluation of basic biochemical indices and wrist X-ray. If these results are normal, TH is most likely the diagnosis and the S-ALP can be monitored over the next three months without further testing. In patients with persisting TH for more than three months and/or in children with pre-existing or suspected metabolic bone disease, further evaluation may be indicated. In conclusion, TH is a benign disorder in patients post-Tx. Detailed investigation including bone biopsy is only indicated in patients with persisting TH.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12024479
- 003
- CZ-PrNML
- 005
- 20150826094530.0
- 007
- ta
- 008
- 120815s2012 dk f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.1111/j.1399-3046.2010.01379.x $2 doi
- 035 __
- $a (PubMed)20819182
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a dk
- 100 1_
- $a Kutílek, Štěpán, $u Department of Pediatrics, Pardubice Hospital, Pardubice, Czech Republic. $d 1957- $7 xx0002376
- 245 10
- $a Transient hyperphosphatasemia in pediatric renal transplant patients--is there a need for concern and when? / $c S. Kutílek, S. Skálová, J. Vethamuthu, P. Geier, J. Feber,
- 520 9_
- $a TH of infancy and early childhood is characterized by transiently increased S-ALP, predominantly its bone or liver isoforms. There are neither signs of metabolic bone disease or hepatopathy corresponding to the increased S-ALP, nor a common underlying/triggering disease. TH may also occur in children post-renal Tx, which may raise significant concerns and anxiety. We describe four patients aged 2.8-7 yr in whom the TH occurred at 11-34 (median = 28) months after Tx and lasted from 40 to 105 (median = 63) days. No obvious cause/trigger of TH could be found; the clinical status and bone turnover were not altered. In cases of TH post-Tx, we recommend the evaluation of basic biochemical indices and wrist X-ray. If these results are normal, TH is most likely the diagnosis and the S-ALP can be monitored over the next three months without further testing. In patients with persisting TH for more than three months and/or in children with pre-existing or suspected metabolic bone disease, further evaluation may be indicated. In conclusion, TH is a benign disorder in patients post-Tx. Detailed investigation including bone biopsy is only indicated in patients with persisting TH.
- 650 _2
- $a alkalická fosfatasa $x krev $7 D000469
- 650 _2
- $a biopsie $7 D001706
- 650 _2
- $a kosti a kostní tkáň $x patologie $7 D001842
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a předškolní dítě $7 D002675
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hyperfosfatemie $x etiologie $x terapie $7 D054559
- 650 _2
- $a transplantace ledvin $x metody $7 D016030
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a nefrotický syndrom $x terapie $7 D009404
- 650 _2
- $a protein - isoformy $7 D020033
- 650 _2
- $a renální insuficience $x terapie $7 D051437
- 650 _2
- $a výsledek terapie $7 D016896
- 650 _2
- $a zápěstí $x radiografie $7 D014953
- 655 _2
- $a kazuistiky $7 D002363
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Skálová, Sylva $7 xx0105263
- 700 1_
- $a Vethamuthu, Jennifer
- 700 1_
- $a Geier, Pavel $7 xx0047399
- 700 1_
- $a Feber, Janusz
- 773 0_
- $w MED00004924 $t Pediatric transplantation $x 1399-3046 $g Roč. 16, č. 1 (2012), s. E5-E9
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/20819182 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m $z 0
- 990 __
- $a 20120815 $b ABA008
- 991 __
- $a 20150826094644 $b ABA008
- 999 __
- $a ok $b bmc $g 946627 $s 781807
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 16 $c 1 $d E5-E9 $i 1399-3046 $m Pediatric transplantation $n Pediatr. transplant. (Online) $x MED00004924
- LZP __
- $b NLK118 $a Pubmed-20120815/12/02